Skyrizi (risankizumab) is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for ...

Two oral presentations to highlight new 76-week data showing sustained proteinuria reduction and continued eGFR stabilization with a consistent long-term safety profileAdditional presentations to high ...

Australia’s biodiversity market could have 10 projects by year-end; SLM Partners closes Silva Fund II with €150 million ABP commitment; Finance Earth and FSD Africa partner for $100 million impact ...

A.I.S. Resources Limited (TSX-V: AIS OTC PINK: AISSF FRA: 5YH) (the Company or A.I.S) is pleased to announce its sponsorship of a ...

For cooling providers, this changes the emphasis from fixed-specification equipment toward ongoing engineering support.

In a Phase 2a study, ABBV-466 achieved higher endoscopic remission rates in patients with Crohn's disease than either anti-IL-23 p19 or anti-α4β7 ...

Researchers working on climate change, diversity, transgender health and international aid have turned to lawsuits, private ...

Beauty companies can make more of two high-value assets they already possess: their scientific organizations and their boards. The key is to connect them deliberately.

AbbVie (NYSE: ABBV) today announced that new and updated data from its broad solid tumor portfolio will be presented at the 2026 European Society for Medical Oncology (ESMO) Congress, taking place ...

Four rapid oral presentations at ESMO will feature new data for INCB161734, a KRAS G12D inhibitor, and INCA338901, a TGFR2×PD-1 bispecific antibody ...